← FDA DRUG APPROVALS

FDA ANDA · ANDA216561

AZELASTINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA216561
TYPE
ANDA
ORIGINAL APPROVAL
2025-01-27
LATEST ACTION
2025-01-27
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Over-the-counter

Products

AZELASTINE HYDROCHLORIDE ALLERGYOver-the-counter
AZELASTINE HYDROCHLORIDE 0.2055MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2025-01-27UNKNOWN · Original · standardLetterTA
2025-01-27UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →